Dr Edmund Lau

Clinical Senior Lecturer
Medicine: Central Clinical School

Telephone 9515 8613

Map

Biographical details

Edmund Lau is a Respiratory Physician at Royal Prince Alfred Hospital. His major clinical and research interests are diseases that affect the pulmonary circulation. He has completed a PhD in pulmonary vascular disease, with further post-doctoral training at the French Reference Centre for Severe Pulmonary Hypertension.

International links

Belgium

(Professor Robert Naeije, Erasme Hospital, Brussels) Right ventricular response to stress in pulmonary arterial hypertension

France

(Professor Denis Chemla, University of Paris-Sud) Haemodynamics of pulmonary circulation; exercise response in pulmonary vascular disease

France

(Professor Marc Humbert, INSERM UMR_S999) Translational and clinical research in pulmonary arterial hypertension

Selected grants

2014

  • Signature olfactive de lhypertension arterielle pulmonaire detectee dans les exhalats pulmonaires par un nez artificiel : de la preuve de concept a la validation; Lau E; Fondation du Souffle/Postdocoral Fellowship.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Lau, E., Humbert, M. (2015). A Critical Appraisal of the Updated 2014 Nice Pulmonary Hypertension Classification System. Canadian Journal of Cardiology, 31(4), 367-374. [More Information]
  • Sharma, T., Lau, E., Choudhary, P., Torzillo, P., Munoz, P., Simmons, L., Naeije, R., Celermajer, D. (2015). Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension. The European Respiratory Journal, 45(3), 700-708. [More Information]
  • Lau, E., Humbert, M., Celermajer, D. (2015). Early detection of pulmonary arterial hypertension. Nature Reviews Cardiology, 12(3), 143-155. [More Information]
  • Lau, E., Celermajer, D., Naeije, R. (2015). The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension. The European Respiratory Journal, 45(6), 1758-1759. [More Information]
  • Marc, H., Lau, E., Montani, D., Jais, X., Sitbon, O., Simonneau, G. (2014). Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension. Circulation, 130(24), 2189-2208. [More Information]
  • Lau, E., Abelson, D., Dwyer, N., Yu, Y., Ng, M., Celermajer, D. (2014). Assessment of ventriculo-arterial interaction in pulmonary arterial hypertension using wave intensity analysis. The European Respiratory Journal, 43(6), 1804-1807. [More Information]
  • Lau, E., Vanderpool, R., Choudhary, P., Simmons, L., Corte, T., Argiento, P., DAlto, M., Naeije, R., Celermajer, D. (2014). Dobutamine Stress Echocardiography for the Assessment of Pressure-Flow Relationships of the Pulmonary Circulation. Chest, 146(4), 959-966. [More Information]
  • Lau, E., Celermajer, D. (2014). Protecting our children from environmental tobacco smoke: one of our great healthcare challenges. European Heart Journal, 35(36), 2452-2453. [More Information]
  • Lau, E., Bailey, D., Bailey, E., Torzillo, P., Roach, P., Schembri, G., Corte, T., Celermajer, D. (2014). Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT study. Heart, 100(1), 47-53. [More Information]
  • Lau, E., Morgan, P., Belousova, E., Toelle, B., Ayer, J., Celermajer, D., Marks, G. (2013). Asymmetric dimethylarginine and asthma: results from the Childhood Asthma Prevention Study. The European Respiratory Journal, 41(5), 1234-1237. [More Information]
  • Lau, E., Jaijee, S., Melehan, K., Wong, K., Yee, B., Grunstein, R., Celermajer, D. (2013). Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. International Journal of Cardiology, 165(1), 35-40. [More Information]
  • Lau, E., McCaughan, G., Torzillo, P. (2012). A case of portopulmonary hypertension spanning 18 years: successful use of bosentan for progressive disease after two liver transplantations. Internal Medicine Journal, 42(5), 600-601. [More Information]
  • Lau, E., Iyer, N., Ilsar, R., Bailey, B., Adams, M., Celermajer, D. (2012). Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound. PloS One, 7(3), 1-6. [More Information]
  • Lau, E., Cooper, W., Bye, P., Yan, K. (2011). Difficult asthma and Churg-Strauss-like syndrome: A cautionary tale. Respirology, 16(1), 180-181. [More Information]
  • Lau, E., Manes, A., Celermajer, D., Galie, N. (2011). Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. European Heart Journal, 32(20), 2489-2498. [More Information]
  • Bye, P., Lau, E., Elkins, M. (2011). Pharmacological airway clearance strategies in bronchiectasis. European Respiratory Monograph, , 239-247.
  • Lau, E., Barnes, D., Moriarty, C., Ogle, R., Dentice, R., Civitico, J., Avedello, A., Torzillo, P., Bye, P. (2011). Pregnancy outcomes in the current era of cystic fibrosis care: A 15-year experience. Australian and New Zealand Journal of Obstetrics and Gynaecology, 51(3), 220-224. [More Information]
  • Iyer, N., Lau, E., Ilsar, R., Celermajer, D. (2011). Treatment responsiveness in pulmonary arterial hypertension-Preliminary report on serial intra-arterial Doppler flow velocity waveform measurements. International Journal of Cardiology, 153(2), 219-221. [More Information]
  • Lau, E., Yee, B., Grunstein, R., Celermajer, D. (2010). Patent foramen ovale and obstructive sleep apnea: A new association? Sleep Medicine Reviews, 14(6), 391-395. [More Information]

2015

  • Lau, E., Humbert, M. (2015). A Critical Appraisal of the Updated 2014 Nice Pulmonary Hypertension Classification System. Canadian Journal of Cardiology, 31(4), 367-374. [More Information]
  • Sharma, T., Lau, E., Choudhary, P., Torzillo, P., Munoz, P., Simmons, L., Naeije, R., Celermajer, D. (2015). Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension. The European Respiratory Journal, 45(3), 700-708. [More Information]
  • Lau, E., Humbert, M., Celermajer, D. (2015). Early detection of pulmonary arterial hypertension. Nature Reviews Cardiology, 12(3), 143-155. [More Information]
  • Lau, E., Celermajer, D., Naeije, R. (2015). The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension. The European Respiratory Journal, 45(6), 1758-1759. [More Information]

2014

  • Marc, H., Lau, E., Montani, D., Jais, X., Sitbon, O., Simonneau, G. (2014). Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension. Circulation, 130(24), 2189-2208. [More Information]
  • Lau, E., Abelson, D., Dwyer, N., Yu, Y., Ng, M., Celermajer, D. (2014). Assessment of ventriculo-arterial interaction in pulmonary arterial hypertension using wave intensity analysis. The European Respiratory Journal, 43(6), 1804-1807. [More Information]
  • Lau, E., Vanderpool, R., Choudhary, P., Simmons, L., Corte, T., Argiento, P., DAlto, M., Naeije, R., Celermajer, D. (2014). Dobutamine Stress Echocardiography for the Assessment of Pressure-Flow Relationships of the Pulmonary Circulation. Chest, 146(4), 959-966. [More Information]
  • Lau, E., Celermajer, D. (2014). Protecting our children from environmental tobacco smoke: one of our great healthcare challenges. European Heart Journal, 35(36), 2452-2453. [More Information]
  • Lau, E., Bailey, D., Bailey, E., Torzillo, P., Roach, P., Schembri, G., Corte, T., Celermajer, D. (2014). Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT study. Heart, 100(1), 47-53. [More Information]

2013

  • Lau, E., Morgan, P., Belousova, E., Toelle, B., Ayer, J., Celermajer, D., Marks, G. (2013). Asymmetric dimethylarginine and asthma: results from the Childhood Asthma Prevention Study. The European Respiratory Journal, 41(5), 1234-1237. [More Information]
  • Lau, E., Jaijee, S., Melehan, K., Wong, K., Yee, B., Grunstein, R., Celermajer, D. (2013). Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. International Journal of Cardiology, 165(1), 35-40. [More Information]

2012

  • Lau, E., McCaughan, G., Torzillo, P. (2012). A case of portopulmonary hypertension spanning 18 years: successful use of bosentan for progressive disease after two liver transplantations. Internal Medicine Journal, 42(5), 600-601. [More Information]
  • Lau, E., Iyer, N., Ilsar, R., Bailey, B., Adams, M., Celermajer, D. (2012). Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound. PloS One, 7(3), 1-6. [More Information]

2011

  • Lau, E., Cooper, W., Bye, P., Yan, K. (2011). Difficult asthma and Churg-Strauss-like syndrome: A cautionary tale. Respirology, 16(1), 180-181. [More Information]
  • Lau, E., Manes, A., Celermajer, D., Galie, N. (2011). Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. European Heart Journal, 32(20), 2489-2498. [More Information]
  • Bye, P., Lau, E., Elkins, M. (2011). Pharmacological airway clearance strategies in bronchiectasis. European Respiratory Monograph, , 239-247.
  • Lau, E., Barnes, D., Moriarty, C., Ogle, R., Dentice, R., Civitico, J., Avedello, A., Torzillo, P., Bye, P. (2011). Pregnancy outcomes in the current era of cystic fibrosis care: A 15-year experience. Australian and New Zealand Journal of Obstetrics and Gynaecology, 51(3), 220-224. [More Information]
  • Iyer, N., Lau, E., Ilsar, R., Celermajer, D. (2011). Treatment responsiveness in pulmonary arterial hypertension-Preliminary report on serial intra-arterial Doppler flow velocity waveform measurements. International Journal of Cardiology, 153(2), 219-221. [More Information]

2010

  • Lau, E., Yee, B., Grunstein, R., Celermajer, D. (2010). Patent foramen ovale and obstructive sleep apnea: A new association? Sleep Medicine Reviews, 14(6), 391-395. [More Information]

To update your profile click here. For support on your academic profile contact .